These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21105944)

  • 1. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
    Rodwin MA
    J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing and Treating Narcotic Addiction--Century of Federal Drug Control.
    Courtwright DT
    N Engl J Med; 2015 Nov; 373(22):2095-7. PubMed ID: 26605925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P;
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract]   [Full Text] [Related]  

  • 7. A historical perspective of pharmaceutical promotion and physician education.
    Podolsky SH; Greene JA
    JAMA; 2008 Aug; 300(7):831-3. PubMed ID: 18714063
    [No Abstract]   [Full Text] [Related]  

  • 8. Keeping modern in medicine: pharmaceutical promotion and physician education in postwar America.
    Greene JA; Podolsky SH
    Bull Hist Med; 2009; 83(2):331-77. PubMed ID: 19502716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical-industrial complex, professional medical associations, and continuing medical education.
    Schofferman J
    Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical marketing research and the prescribing physician.
    Greene JA
    Ann Intern Med; 2007 May; 146(10):742-8. PubMed ID: 17502635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
    Rodwin MA
    J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associations.
    Shnier A; Lexchin J
    Int J Risk Saf Med; 2017; 29(1-2):1-16. PubMed ID: 28885217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CME, physicians, and Pavlov: can we change what happens when industry rings the bell?
    Lichter PR
    Trans Am Ophthalmol Soc; 2008; 106():39-43; discussion 44-5. PubMed ID: 19277219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional dependence? A social history of the medical use of morphine in Australia.
    Grant M; Philip J; Ugalde A
    Med J Aust; 2014 Mar; 200(4):230-2. PubMed ID: 24580529
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing medical education: AMEE Education Guide No 35.
    Davis N; Davis D; Bloch R
    Med Teach; 2008; 30(7):652-66. PubMed ID: 18777424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uncertain future of continuing medical education: commercialism and shifts in funding.
    Van Harrison R
    J Contin Educ Health Prof; 2003; 23(4):198-209. PubMed ID: 14730790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflict of interest in CME.
    Nelson R
    Iowa Med; 1994 Dec; 84(12):541. PubMed ID: 7843923
    [No Abstract]   [Full Text] [Related]  

  • 19. Take this medicine: the legality of prescription incentive schemes.
    Fanning J; Glover-Thomas N
    Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuing medical education effect on practice performance: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines.
    Davis D; Galbraith R;
    Chest; 2009 Mar; 135(3 Suppl):42S-48S. PubMed ID: 19265075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.